Emerging Infectious Diseases

Emerging and re-emerging infectious diseases continue to pose significant challenges to global public health, healthcare systems, and socioeconomic stability. The increasing frequency of outbreaks caused by novel pathogens, alongside the resurgence of previously controlled infectious diseases, highlights the urgent need for enhanced surveillance, rapid detection, effective response strategies, and international collaboration. Factors such as globalization, urbanization, climate change, population growth, environmental disruption, antimicrobial resistance, and increased human-animal interactions have contributed to the emergence and spread of infectious diseases across regions and continents. This session focuses on the epidemiology, transmission dynamics, pathogenesis, prevention, and control of emerging and re-emerging infectious diseases affecting human populations worldwide. Participants will explore current and future threats posed by viral, bacterial, fungal, and parasitic pathogens, including newly identified infectious agents and diseases that have reappeared due to changing environmental and societal conditions. Discussions will cover outbreak investigation, disease surveillance systems, early warning mechanisms, risk assessment methodologies, and innovative approaches to public health preparedness. The session will also examine lessons learned from recent epidemics and pandemics, emphasizing the importance of coordinated global responses, resilient healthcare infrastructures, and evidence-based interventions. Special attention will be given to the role of scientific research, technological advancements, genomic surveillance, and interdisciplinary collaboration in understanding disease emergence and mitigating public health risks. Researchers and healthcare professionals will have the opportunity to present findings related to pathogen evolution, host-pathogen interactions, disease modeling, and emerging diagnostic and therapeutic approaches. Additionally, the session will address challenges associated with disease containment in resource-limited settings, cross-border health threats, and the integration of One Health principles into infectious disease prevention and response strategies. By fostering dialogue among scientists, clinicians, public health experts, policymakers, and industry representatives, this session aims to promote innovative solutions and collaborative efforts that strengthen global preparedness and resilience against infectious disease threats. The insights shared during this session will contribute to advancing knowledge, improving public health practices, and supporting the development of sustainable strategies for preventing and managing emerging and re-emerging infectious diseases in an increasingly interconnected world.

Epidemiology, surveillance, and outbreak investigation form the foundation of infectious disease prevention and control, enabling public health authorities and healthcare professionals to detect, monitor, and respond to disease threats effectively. As infectious diseases continue to evolve and spread across geographic boundaries, robust surveillance systems and advanced epidemiological methods have become increasingly important for safeguarding global health. This session focuses on the latest developments in epidemiological research, disease monitoring technologies, outbreak detection, and response strategies aimed at reducing the impact of infectious diseases on populations worldwide. Participants will explore modern approaches to disease surveillance, including digital health technologies, real-time reporting systems, geographic information systems, genomic epidemiology, and artificial intelligence-driven analytics. The session will highlight the critical role of data collection, interpretation, and dissemination in identifying disease trends, tracking transmission patterns, and informing public health decision-making. Discussions will cover outbreak investigation methodologies, contact tracing strategies, risk assessment frameworks, and the integration of laboratory and field-based surveillance data to support rapid response efforts. Special attention will be given to surveillance challenges in resource-limited settings, cross-border disease monitoring, and the importance of international cooperation in addressing global health emergencies. Presentations may examine case studies from recent outbreaks and pandemics, demonstrating how epidemiological evidence has guided interventions and policy development. The session will also address emerging tools for predictive modeling, disease forecasting, and early warning systems designed to improve preparedness and response capabilities. Researchers, epidemiologists, public health practitioners, healthcare professionals, and policymakers will have opportunities to share innovative findings related to infectious disease surveillance, outbreak analytics, population health monitoring, and public health intelligence. Furthermore, discussions will explore ethical considerations, data privacy concerns, and strategies for strengthening surveillance infrastructure in diverse healthcare environments. By bringing together experts from academia, healthcare, government agencies, and international organizations, this session aims to foster collaboration and knowledge exchange that support timely detection and effective management of infectious disease threats. The insights generated through these discussions will contribute to enhancing public health resilience, improving outbreak preparedness, and advancing evidence-based approaches for disease prevention and control in an increasingly interconnected and rapidly changing world.

Antimicrobial resistance (AMR) has emerged as one of the most pressing global health challenges of the twenty-first century, threatening the effectiveness of antibiotics, antivirals, antifungals, and antiparasitic medications that have transformed modern medicine. The increasing prevalence of drug-resistant pathogens compromises the treatment of infectious diseases, prolongs hospital stays, increases healthcare costs, and contributes significantly to morbidity and mortality worldwide. This session will explore the scientific, clinical, and public health dimensions of antimicrobial resistance while highlighting innovative approaches to infection prevention and control. Participants will examine the mechanisms underlying resistance development, including genetic mutations, horizontal gene transfer, selective antimicrobial pressure, and environmental influences that facilitate the emergence and spread of resistant microorganisms. Discussions will focus on major resistant pathogens affecting healthcare and community settings, surveillance strategies for monitoring antimicrobial resistance trends, and the implementation of antimicrobial stewardship programs aimed at optimizing medication use and preserving treatment effectiveness. The session will also address infection prevention measures, including healthcare-associated infection control practices, hygiene interventions, environmental decontamination, vaccination strategies, and public awareness initiatives. Researchers and healthcare professionals will present findings related to novel antimicrobial agents, alternative therapeutic approaches, rapid diagnostic technologies, and emerging tools for resistance detection and management. Special emphasis will be placed on multidisciplinary collaboration among clinicians, microbiologists, pharmacists, infection control practitioners, policymakers, and public health agencies to combat resistance at local, national, and global levels. By fostering knowledge exchange and scientific dialogue, this session aims to support sustainable solutions that strengthen infection control practices and address the growing threat of antimicrobial resistance.

Vaccination remains one of the most successful and cost-effective public health interventions for preventing infectious diseases, reducing mortality, and improving population health outcomes worldwide. As emerging and re-emerging infectious diseases continue to challenge global healthcare systems, the development of safe, effective, and accessible vaccines has become increasingly important for disease prevention and outbreak preparedness. This session focuses on recent advancements in vaccine research, immunology, immunization programs, and preventive healthcare strategies designed to protect communities against infectious threats. Participants will explore cutting-edge developments in vaccine design, including mRNA technologies, viral vector platforms, recombinant vaccines, protein-based formulations, and next-generation immunization approaches. Discussions will cover vaccine efficacy, safety monitoring, clinical trial advancements, regulatory considerations, and strategies for accelerating vaccine development during public health emergencies. The session will also examine immunization policies, vaccine delivery systems, cold-chain management, vaccine equity, and methods for improving public confidence and vaccination coverage across diverse populations. Researchers will present findings on immune responses, correlates of protection, long-term vaccine effectiveness, and innovations aimed at addressing emerging pathogens. Additional topics include maternal immunization, pediatric vaccination programs, adult immunization strategies, and the role of vaccines in preventing antimicrobial resistance and reducing disease burden. By bringing together scientists, clinicians, public health professionals, policymakers, and industry leaders, this session aims to advance scientific understanding and promote collaborative efforts that strengthen global immunization programs and improve preparedness for future infectious disease challenges.

Emerging viral diseases continue to represent a major threat to global public health due to their ability to spread rapidly across populations, disrupt healthcare systems, and cause significant social and economic consequences. Recent outbreaks and pandemics have demonstrated the importance of early detection, rapid response, scientific collaboration, and resilient healthcare infrastructures in mitigating the impact of viral pathogens. This session focuses on the epidemiology, virology, transmission dynamics, prevention, and management of emerging viral diseases while emphasizing the critical role of pandemic preparedness in strengthening global health security. Participants will explore the biological characteristics and evolution of emerging viruses, including factors that contribute to zoonotic spillover, viral adaptation, and cross-border transmission. Discussions will cover surveillance systems, genomic monitoring, outbreak investigation, risk assessment, and predictive modeling approaches that support timely identification of emerging viral threats. The session will also examine advances in diagnostic technologies, antiviral therapeutics, vaccine development, and public health interventions designed to reduce disease transmission and improve patient outcomes. Special attention will be given to lessons learned from recent global outbreaks and pandemics, highlighting best practices in emergency preparedness, healthcare capacity building, risk communication, and coordinated response strategies. Researchers, clinicians, epidemiologists, virologists, public health officials, and policymakers will have opportunities to share findings related to viral pathogenesis, host immune responses, outbreak management, and innovative technologies for pandemic prevention and control. Additional topics include international collaboration, pandemic preparedness planning, healthcare workforce readiness, supply chain resilience, and the integration of One Health approaches to address viral threats at the human-animal-environment interface. By fostering interdisciplinary dialogue and knowledge exchange, this session aims to promote evidence-based strategies that enhance preparedness, strengthen response capabilities, and improve global resilience against future viral outbreaks and pandemics. The insights generated through these discussions will contribute to advancing scientific understanding, informing public health policy, and supporting sustainable efforts to protect populations from emerging viral diseases worldwide.

Zoonotic diseases account for a significant proportion of emerging infectious diseases worldwide, highlighting the interconnected relationship between human health, animal health, and environmental sustainability. This session explores the transmission, prevention, surveillance, and control of zoonotic infections while emphasizing the importance of the One Health framework in addressing complex public health challenges. Discussions will focus on pathogen spillover events, wildlife reservoirs, livestock-associated infections, environmental factors influencing disease emergence, and interdisciplinary strategies for reducing zoonotic risks. Participants will examine advances in surveillance systems, outbreak investigation, diagnostic technologies, and collaborative interventions involving veterinarians, public health experts, environmental scientists, and policymakers. The session aims to promote integrated solutions that strengthen preparedness and improve responses to zoonotic disease threats globally.

Accurate and timely diagnosis is essential for effective infectious disease management, outbreak control, and public health decision-making. This session focuses on emerging diagnostic technologies, laboratory advancements, and innovative testing strategies that enhance disease detection and monitoring. Topics include molecular diagnostics, point-of-care testing, genomic sequencing, biomarker discovery, artificial intelligence-assisted diagnostics, and laboratory quality assurance. Participants will explore how modern laboratory medicine supports surveillance programs, clinical care, and public health interventions. Discussions will also address challenges related to diagnostic accessibility, affordability, and implementation in diverse healthcare settings. The session provides a platform for showcasing novel diagnostic tools that improve patient outcomes and strengthen healthcare systems.

Global health security requires coordinated efforts to prevent, detect, and respond to infectious disease threats that transcend national borders. This session examines strategies for strengthening public health preparedness, emergency response systems, and international cooperation in managing outbreaks and health emergencies. Participants will discuss risk assessment, emergency planning, healthcare system resilience, policy development, and public health infrastructure enhancement. The session will highlight lessons learned from recent outbreaks and explore innovative approaches for improving preparedness at local, national, and global levels. By fostering collaboration among governments, healthcare organizations, researchers, and international agencies, this session aims to support sustainable strategies that protect populations from future infectious disease threats.

Climate change is increasingly recognized as a major driver of infectious disease emergence and transmission, influencing pathogen distribution, vector ecology, and environmental conditions that affect public health. This session explores the relationship between climate variability and infectious diseases, including vector-borne, waterborne, and zoonotic infections. Discussions will focus on changing disease patterns, environmental surveillance, predictive modeling, adaptation strategies, and public health interventions designed to address climate-related health risks. Participants will examine scientific evidence linking climate factors to disease outbreaks and explore multidisciplinary approaches that integrate environmental science, epidemiology, and public health policy. The session aims to promote resilience and preparedness in the face of evolving environmental challenges.

Real-world outbreak experiences provide invaluable insights into the complexities of infectious disease detection, clinical management, public health response, and healthcare system preparedness. This session focuses on case studies, clinical experiences, and lessons learned from infectious disease outbreaks across diverse geographic and healthcare settings. Participants will explore successful interventions, emerging challenges, and evidence-based practices derived from outbreak investigations, epidemic responses, and pandemic management efforts. Discussions will cover clinical presentations, diagnostic challenges, treatment strategies, infection prevention measures, healthcare system responses, and multidisciplinary approaches to outbreak control. The session will also examine the role of surveillance systems, public health policies, risk communication, community engagement, and international collaboration in managing infectious disease emergencies. Researchers, clinicians, epidemiologists, public health officials, and healthcare administrators will have opportunities to present case reports, outbreak analyses, implementation experiences, and translational research findings that contribute to improved preparedness and response capabilities. Special emphasis will be placed on lessons learned from recent global and regional outbreaks, including strategies that enhanced resilience, reduced disease transmission, and improved patient outcomes. Additional topics include healthcare workforce readiness, ethical considerations during public health emergencies, operational challenges, and innovations that emerged from outbreak response efforts. By facilitating interdisciplinary dialogue and practical knowledge sharing, this session aims to strengthen preparedness, improve clinical and public health decision-making, and support the development of resilient healthcare systems capable of effectively addressing future infectious disease threats.

The continuous evolution of infectious pathogens and the emergence of drug-resistant microorganisms have created an urgent need for innovative therapeutic strategies and accelerated drug development efforts. Infectious disease therapeutics play a critical role in reducing disease burden, improving patient outcomes, and strengthening global preparedness against current and future health threats. This session focuses on the discovery, development, evaluation, and clinical application of therapeutic interventions for infectious diseases, highlighting advances in pharmaceuticals, biologics, antiviral agents, antimicrobial therapies, immunotherapies, and precision medicine approaches. Participants will explore the latest breakthroughs in drug discovery, translational research, and clinical development pathways aimed at addressing bacterial, viral, fungal, and parasitic infections. Discussions will cover novel therapeutic targets, host-directed therapies, monoclonal antibodies, combination treatments, drug repurposing strategies, and emerging technologies that accelerate therapeutic innovation. The session will also examine challenges associated with antimicrobial resistance, treatment optimization, clinical trial design, regulatory approval processes, and equitable access to life-saving medicines. Researchers, clinicians, pharmaceutical scientists, biotechnology professionals, regulatory experts, and public health stakeholders will have opportunities to share findings related to preclinical studies, clinical investigations, therapeutic efficacy, safety assessments, and real-world treatment outcomes. Special attention will be given to personalized treatment strategies, pharmacogenomics, advanced drug delivery systems, and the integration of artificial intelligence and computational tools in drug development. Additional topics include pandemic therapeutics, emergency use authorizations, global manufacturing capacity, supply chain resilience, and collaborative partnerships that support rapid therapeutic deployment during public health emergencies. By fostering interdisciplinary collaboration and scientific exchange, this session aims to advance the development of safe, effective, and accessible treatments that improve infectious disease management and contribute to global health security. The insights generated through these discussions will support innovation, accelerate therapeutic discovery, and strengthen healthcare systems in addressing evolving infectious disease challenges worldwide.

Healthcare-associated infections (HAIs) remain a significant challenge for healthcare systems worldwide, affecting millions of patients each year and contributing to increased morbidity, mortality, prolonged hospital stays, and rising healthcare costs. Preventing and controlling infections acquired within healthcare settings is essential for ensuring patient safety, improving healthcare quality, and strengthening public confidence in healthcare services. This session focuses on the epidemiology, prevention, surveillance, and management of healthcare-associated infections while highlighting evidence-based strategies that promote safer healthcare environments. Participants will explore the major types of HAIs, including bloodstream infections, surgical site infections, ventilator-associated pneumonia, catheter-associated urinary tract infections, and infections caused by multidrug-resistant organisms. Discussions will cover infection prevention and control practices, hand hygiene compliance, environmental cleaning and disinfection, sterilization procedures, antimicrobial stewardship, and healthcare worker safety. The session will also examine advances in surveillance systems, diagnostic technologies, outbreak investigation, healthcare quality improvement initiatives, and patient-centered approaches that reduce infection risks and improve clinical outcomes. Researchers, clinicians, infection prevention specialists, microbiologists, nurses, hospital administrators, and public health professionals will have opportunities to present findings related to infection control interventions, healthcare epidemiology, patient safety programs, and innovative technologies designed to minimize healthcare-associated infections. Special attention will be given to challenges faced by healthcare facilities in resource-limited settings, strategies for strengthening infection prevention infrastructure, and the role of education and training in fostering a culture of safety. Additional topics include emerging pathogens in healthcare environments, risk assessment methodologies, regulatory standards, accreditation requirements, and the impact of digital health technologies on infection monitoring and prevention. By bringing together experts from multiple disciplines, this session aims to promote collaboration, knowledge exchange, and the implementation of best practices that enhance patient safety and reduce the burden of healthcare-associated infections. The insights shared during this session will contribute to the development of resilient healthcare systems capable of delivering high-quality, safe, and effective care while minimizing infectious disease risks across diverse healthcare settings.

Infectious diseases remain a major cause of morbidity and mortality among children, pregnant women, and newborns worldwide. The unique physiological and immunological characteristics of these populations require specialized approaches to disease prevention, diagnosis, treatment, and long-term management. This session focuses on the latest advances in pediatric and maternal infectious diseases, addressing critical challenges and opportunities in protecting vulnerable populations from infectious threats. Participants will explore the epidemiology, clinical manifestations, and management of infections affecting infants, children, adolescents, pregnant women, and neonates. Discussions will cover congenital and perinatal infections, vaccine-preventable diseases, maternal immunization, neonatal sepsis, respiratory infections, emerging pediatric pathogens, and strategies for reducing infectious disease burden in maternal and child health programs. The session will also examine innovations in diagnostics, therapeutics, preventive care, and public health interventions that improve outcomes for mothers and children. By fostering collaboration among pediatricians, obstetricians, infectious disease specialists, researchers, and public health professionals, this session aims to advance evidence-based practices that strengthen maternal and child health globally.

The increasing movement of people, goods, and services across international borders has accelerated the spread of infectious diseases and created new challenges for global health security. Travel medicine plays a critical role in preventing disease transmission, protecting travelers, and supporting public health preparedness in an interconnected world. This session explores the impact of international travel, migration, mass gatherings, and globalization on infectious disease emergence and spread. Participants will examine travel-related infections, border health measures, vaccination requirements, disease surveillance, risk assessment, and outbreak response strategies. Discussions will also address emerging global health threats, vector-borne diseases, antimicrobial resistance, and the role of international collaboration in managing cross-border health risks. Researchers and healthcare professionals will share insights into innovative approaches that enhance traveler health, improve disease prevention, and strengthen global response capabilities to emerging infectious threats.

As infectious disease threats continue to evolve, scientific innovation, technological advancement, and international collaboration are becoming increasingly important in shaping the future of global health. This session focuses on emerging trends, breakthrough discoveries, and forward-looking strategies that will influence infectious disease research, prevention, and control in the coming decades. Participants will explore developments in genomics, precision medicine, artificial intelligence, predictive analytics, advanced therapeutics, next-generation vaccines, and digital health technologies. Discussions will highlight the importance of multidisciplinary partnerships, data sharing, research networks, and international cooperation in addressing complex infectious disease challenges. The session will also examine policy priorities, funding opportunities, research capacity building, and strategies for strengthening global preparedness against future outbreaks and pandemics. By bringing together experts from academia, healthcare, industry, government agencies, and international organizations, this session aims to foster innovation, inspire collaboration, and support the development of sustainable solutions that enhance global resilience to infectious disease threats.

Advances in genomic technologies have revolutionized the understanding, detection, and monitoring of infectious diseases, enabling scientists and public health professionals to track pathogen evolution with unprecedented precision. Genomic surveillance has become an essential component of modern infectious disease control, providing critical insights into pathogen emergence, transmission dynamics, mutation patterns, and the development of drug resistance. This session focuses on the application of genomics and molecular epidemiology in infectious disease surveillance, outbreak investigation, and public health decision-making. Participants will explore cutting-edge sequencing technologies, bioinformatics tools, phylogenetic analysis, and genomic data integration methods that support the identification and characterization of emerging pathogens. Discussions will cover the evolution of viruses, bacteria, fungi, and parasites, including mechanisms of genetic variation, adaptation, virulence enhancement, and antimicrobial resistance development. The session will also examine the role of genomic surveillance in monitoring disease outbreaks, detecting variants of concern, informing vaccine development, guiding therapeutic interventions, and strengthening pandemic preparedness efforts. Researchers, microbiologists, epidemiologists, clinicians, bioinformaticians, and public health professionals will have opportunities to present findings related to pathogen genomics, molecular evolution, transmission mapping, and real-time surveillance systems. Special attention will be given to global data-sharing initiatives, ethical considerations, laboratory capacity building, and the integration of genomic technologies into routine public health practice. Additional topics include metagenomics, environmental surveillance, genomic forecasting, precision public health, and the use of artificial intelligence to analyze large-scale genomic datasets. By fostering interdisciplinary collaboration and scientific exchange, this session aims to advance understanding of pathogen evolution and promote innovative genomic approaches that enhance disease surveillance, outbreak response, and global health security. The knowledge generated through this session will contribute to more effective infectious disease prevention, control, and preparedness strategies in an increasingly interconnected world.

Tropical and neglected infectious diseases continue to affect more than one billion people worldwide, disproportionately impacting populations living in low- and middle-income countries. These diseases contribute significantly to morbidity, disability, socioeconomic burden, and health inequities, often affecting communities with limited access to healthcare, sanitation, education, and disease prevention resources. Despite considerable progress in disease control and elimination efforts, many tropical and neglected infectious diseases remain major public health concerns, requiring sustained research, innovation, and international collaboration. This session focuses on the epidemiology, prevention, diagnosis, treatment, and control of tropical and neglected infectious diseases while highlighting emerging challenges and opportunities for improving global health outcomes. Participants will explore diseases caused by parasitic, bacterial, viral, and fungal pathogens, including malaria, dengue, chikungunya, leishmaniasis, schistosomiasis, lymphatic filariasis, Chagas disease, human African trypanosomiasis, and other neglected tropical diseases. Discussions will cover disease transmission dynamics, vector ecology, environmental determinants of health, surveillance systems, outbreak preparedness, and community-based intervention strategies. The session will also examine advances in diagnostic technologies, vaccine development, therapeutics, vector control programs, and integrated disease management approaches aimed at reducing disease burden and supporting elimination goals. Researchers, clinicians, epidemiologists, public health professionals, policymakers, and representatives from governmental and non-governmental organizations will have opportunities to present findings related to disease control initiatives, implementation science, health systems strengthening, and innovative public health solutions. Special attention will be given to health equity, access to care, capacity building, and the role of international partnerships in addressing neglected infectious diseases. Additional topics include climate change impacts, emerging vector-borne diseases, antimicrobial resistance in tropical settings, and the integration of One Health principles into disease prevention and control programs. By fostering multidisciplinary collaboration and knowledge exchange, this session aims to advance scientific understanding, support evidence-based interventions, and accelerate progress toward the control, elimination, and eventual eradication of tropical and neglected infectious diseases. The insights generated through this session will contribute to strengthening global health systems and improving the lives of vulnerable populations affected by these persistent infectious disease challenges.

Effective public health policy, transparent risk communication, and meaningful community engagement are essential components of infectious disease prevention, outbreak response, and health emergency management. The success of public health interventions often depends not only on scientific evidence and healthcare capacity but also on public trust, stakeholder collaboration, and the timely dissemination of accurate information. This session focuses on the development and implementation of public health policies, communication strategies, and community-centered approaches that strengthen preparedness and response to infectious disease threats. Participants will explore the role of governments, public health agencies, healthcare organizations, and community leaders in designing policies that support disease prevention, surveillance, vaccination programs, and emergency preparedness initiatives. Discussions will examine evidence-based policymaking, health governance, regulatory frameworks, international health regulations, and strategies for balancing public health priorities with social, economic, and ethical considerations. The session will also address risk communication principles, crisis communication planning, media engagement, misinformation management, health literacy, and the use of digital platforms to deliver accurate public health messages during outbreaks and health emergencies. Researchers, policymakers, public health professionals, communication specialists, healthcare providers, and community organizations will have opportunities to share experiences and best practices related to community outreach, behavioral health interventions, stakeholder engagement, and public trust building. Special attention will be given to culturally sensitive communication, addressing vaccine hesitancy, promoting public participation in health initiatives, and strengthening partnerships between health authorities and local communities. Additional topics include emergency communication systems, social and behavioral determinants of health, public perception of risk, and innovative approaches for enhancing community resilience during infectious disease outbreaks. By fostering interdisciplinary collaboration and knowledge exchange, this session aims to advance strategies that improve public understanding, encourage informed decision-making, and strengthen public confidence in health systems. The insights generated through these discussions will contribute to more effective public health policies, enhanced community engagement, and resilient societies capable of responding to current and future infectious disease challenges.

Foodborne and waterborne infectious diseases remain major public health concerns worldwide, affecting millions of people annually and contributing significantly to morbidity, mortality, and economic burden. Contaminated food and water serve as important vehicles for the transmission of bacterial, viral, parasitic, and toxin-mediated infections, particularly in regions with inadequate sanitation, food safety systems, and access to clean drinking water. This session focuses on the epidemiology, prevention, detection, and control of foodborne and waterborne diseases while addressing emerging challenges associated with globalization, climate change, urbanization, and changing food production practices. Participants will explore the transmission dynamics of pathogens such as Salmonella, Escherichia coli, Vibrio cholerae, Campylobacter, Norovirus, Hepatitis A virus, Cryptosporidium, and other infectious agents associated with food and water contamination. Discussions will cover food safety regulations, water quality monitoring, outbreak investigation, laboratory diagnostics, surveillance systems, and risk assessment methodologies. The session will also examine innovative approaches to food safety management, environmental monitoring, public health interventions, sanitation programs, and community education initiatives aimed at reducing disease burden. Researchers, microbiologists, epidemiologists, environmental health specialists, food safety experts, public health professionals, and policymakers will have opportunities to present findings related to pathogen detection, contamination prevention, antimicrobial resistance, and emerging foodborne and waterborne threats. Special attention will be given to sustainable food systems, climate-related impacts on disease transmission, and global strategies for ensuring food and water security. By promoting scientific collaboration and knowledge exchange, this session aims to advance evidence-based solutions that improve food and water safety and protect public health worldwide.